InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the full record of transactions filed by BIGHAM MICHAEL, Chairman & CEO. Officer active across 2 companies, notably Adamas Pharmaceuticals Inc. In total, 11 filings have been published. Total volume traded: €40k. The latest transaction was filed on 15 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
0202,500 shares0
Common Stock
SEC:0000904454-22-000262:0·
€19,7685,059 shares@ €3.9074100.0% of flow
Common Stock
SEC:0000904454-21-000846·
€19,7685,059 shares@ €3.907450.0% of flow
Common Stock
SEC:0000904454-21-000846:0·
10,000 shares
Common Stock
SEC:0001328143-21-000095·
10,000 shares
Common Stock
SEC:0001328143-21-000095:0·
075,000 shares0
Common Stock
SEC:0000904454-21-000626·
075,000 shares0
Common Stock
SEC:0000904454-21-000626:0·
085,909 shares0
Common Stock
SEC:0000904454-21-000514·
085,909 shares0
Common Stock
SEC:0000904454-21-000514:0·
05,000 shares0
Common Stock
SEC:0001328143-21-000054·
05,000 shares0
Common Stock
SEC:0001328143-21-000054:0·
11 of 11 declarations
About BIGHAM MICHAEL
Michael Bigham is the Chairman & CEO of Adamas Pharmaceuticals Inc. and other companies. He leads the operations and strategy of the company, which focuses on developing treatments for neurological diseases. His leadership is crucial in guiding research and development, as well as establishing strategic partnerships in the pharmaceutical sector.
